Recipharm invests in expanding filling capacity at Monts facility

After securing a 5-year, €90 million ($113.2 million) loan, Swedish CDMO Recipharm is making an investment into expanding its filling capacity at its Monts, France, facility with a new state-of-the-art filling machine.

The Dara cartridge filling machine, which cost around €600,000 (approximately $756,000), will allow the facility to produce 7,200 cartridges per hour, according to a company release.

"This should not only reduce lead times but also increase reliability and flexibility. It also complements very well the vial filling activity which we perform here too," said Michel Saudemon, of the Monts facility, in a statement. "Our well-developed technology transfer and project management processes are clearly a key component of the offering, and it is allowing us to deliver a high quality service to clients both new and old."

Filling services for manufacturers and drug delivers have become hot as of late. Catalent Pharma Solutions recently completed a renovation of a clinical manufacturing suite in North Carolina should provide a "fourfold increase" of the sterile fill-finish capacity at the facility, while Siegfried Holding AG recently purchased Allied Medical Products for $58 million, with its eyes on getting into the sterile filling market.

- here's the release

Suggested Articles

The money will be used to expand its footprint in both China and the U.S., including a new R&D operation in Boston.

The CRO will transfer most of its Pennsylvania-based biologics laboratory functions to a new, 73,000-square-foot site on Devon Park in Wayne.

Monoclonal antibodies developer Xencor extended a strategic alliance formed in 2016 with Selexis with four commercial license agreements.